معرفی
Adam Handel is an MRC New Investigator Associate Professor at the University of Oxford and Consultant Neurologist at Oxford University Hospitals NHS Foundation Trust. He is affiliated with Wadham College and works within the Nuffield Department of Clinical Neurosciences (NDCN), as indicated by his institutional email address. Dr. Handel heads the Oxford Autoimmune Neurology Group and runs the Oxford Autoimmune Neurology Clinic at the John Radcliffe Hospital, serving as a national referral center for autoimmune encephalitis cases across the UK.
His research program focuses on understanding the molecular immunopathogenesis of neuroinflammatory conditions, with particular emphasis on autoimmune encephalitis. Dr. Handel has identified clinical features characterizing multiple autoantibody-mediated neurological conditions and has pioneered high-throughput single-cell sequencing approaches using peripheral blood and cerebrospinal fluid from patients. A key focus of his work is investigating the previously understudied role of T cells in autoimmune encephalitis, exploring how autoreactive T cells escape thymic negative selection and contribute to disease pathogenesis. His work bridges basic immunology with clinical neurology through functional genomics, single-cell sequencing, and multiplexed spatial proteomics techniques.
Analysis of Dr. Handel's recent publications (2022-2025) reveals a cohesive research trajectory examining specific autoimmune encephalitis subtypes (LGI1, CASPR2, NMDA receptor antibody encephalitis), with increasing sophistication in methodology from single-cell RNA sequencing to multi-omics approaches. His work spans molecular mechanisms, clinical manifestations, and patient-centered outcomes, demonstrating a translational research pipeline from bench to bedside.
Dr. Handel is funded by major research bodies including the Wellcome Trust and Medical Research Council (MRC), where he holds a New Investigator award. He actively contributes to medical education, regularly teaching undergraduate medical students at the University of Oxford and providing specialized training for doctors on autoimmune encephalitis and functional neurological disorders.
As leader of the Oxford Autoimmune Neurology Group, Dr. Handel directs a multidisciplinary research team investigating the immune system's role in central nervous system autoimmunity. His clinical work at the John Radcliffe Hospital involves comprehensive assessment and treatment of patients with diverse autoimmune neurologic conditions, positioning him at the forefront of both research and clinical care in this specialized field.
